NeuroTherapia Competitors and Similar CompaniesClear all
NeuroTherapia's competitors and similar companies include Invivyd, Quince Therapeutics Italy and NextCure.
 NeuroTherapia NeuroTherapia is a company that develops a medical research platform intended to offer therapies to cure the neuroinflammation spectrum of diseases. |  Invivyd Invivyd (also known as Invivyd Security) is a biopharmaceutical company that develops a platform for infectious viral disease treatment solutions. |  Quince Therapeutics Italy Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | |
Founding Date | Founding Date 2015 | Founding Date 2020 | Founding Date 2007 | Founding Date 2015 |
Type | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Gates Mills, US HQ | Locations HQ | Locations Bresso, IT HQ Tre Torri, IT | Locations Beltsville, US HQ |
Employees | Employees 8 | Employees N/A | Employees 19 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 108.3 m | Valuation ($) N/A | Valuation ($) 39.2 m |
Funding | ||||
Total funding raised | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised $ 35.6m | Total funding raised $ 160m |
For sources of this data, please see the company profile
View Company Profiles
Invivyd
HQ
Invivyd (also known as Invivyd Security) is a biopharmaceutical company that develops a platform for infectious viral disease treatment solutions.
View companyQuince Therapeutics Italy
HQ
Bresso, IT
Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells.
View companyNextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company